Neuropharmacological effects of the aqueous extract of Nauclea latifolia root bark in rats and mice, Journal of Ethnopharmacology, vol.97, issue.1, pp.53-57, 2005. ,
DOI : 10.1016/j.jep.2004.10.003
Incidence of central post-stroke pain, Pain, vol.61, issue.2, pp.187-193, 1995. ,
DOI : 10.1016/0304-3959(94)00144-4
Arbres, arbustes et lianes des zones sèches d'Afrique de l'Ouest Trees, shrubs and lianas of West Africa dry zones, 2000. ,
Chemical constituents of Nauclea latifolia and their anti-GST and anti-fungal activities, Natural Product Communications, vol.4, pp.1185-1188, 2009. ,
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man, Pain, vol.33, issue.1, pp.87-107, 1988. ,
DOI : 10.1016/0304-3959(88)90209-6
Neuropathic pain, p.20, 2007. ,
DOI : 10.1093/med/9780199563678.001.0001
Contribution à l'étude de la flore du Cameroun: les Astéracées, Thèse de doctorat, pp.10-50, 1986. ,
Behavioral signs of ongoing pain and cold alodynia in a rat model of neuropathic pain, Pain, vol.59, pp.369-376, 1994. ,
The useful plants of West Tropical Africa, The Crown Agency for the Colonies, 1937. ,
The Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes, Diabetes Care, vol.29, issue.7, pp.1518-1522, 2006. ,
DOI : 10.2337/dc05-2228
Pharmacological characterization of the chronic constriction injury model of neuropathic pain, European Journal of Pharmacology, vol.491, issue.2-3, pp.137-148, 2004. ,
DOI : 10.1016/j.ejphar.2004.03.051
Anti-nociceptive synergism of morphine and gabapentin in neuropathic pain induced by chronic constriction injury, Pharmacology Biochemistry and Behavior, vol.92, issue.3, pp.457-464, 2009. ,
DOI : 10.1016/j.pbb.2009.01.013
Comparison of five different rat models of peripheral nerve injury, Pharmacology Biochemistry and Behavior, vol.80, issue.1, pp.93-108, 2005. ,
DOI : 10.1016/j.pbb.2004.10.016
Pain syndromes and etiologies in ambulatory AIDS patients, Pain, vol.70, issue.2, pp.117-123, 1997. ,
DOI : 10.1016/S0304-3959(96)03281-2
Risk factors for postherpetic neuralgia in patients with herpes zoster, Neurology, vol.62, issue.9, pp.1545-1555, 2004. ,
DOI : 10.1212/01.WNL.0000123261.00004.29
Persistent postsurgical pain: risk factors and prevention, The Lancet, vol.367, issue.9522, pp.1618-1643, 2006. ,
DOI : 10.1016/S0140-6736(06)68700-X
An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat, Pain, vol.50, issue.3, pp.355-63, 1992. ,
DOI : 10.1016/0304-3959(92)90041-9
A simplified method of evaluating dose-effect experiments, Journal of Pharmacology and Experimental Therapeutics, vol.96, pp.99-113, 1949. ,
A new model to assess analgesic activity: pain-induced functional impairment in the rat (PIFIR) Drug Development Research, pp.169-75, 1993. ,
The definition of pain, European Journal of Psychiatry, vol.6, pp.153-162, 1991. ,
Immune and inflammatory mechanisms in neuropathic pain, Brain Research Reviews, vol.51, issue.2, pp.240-64, 2006. ,
DOI : 10.1016/j.brainresrev.2005.11.004
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1983. ,
DOI : 10.1016/0022-1759(83)90303-4
Anticonvulsant, anxiolytic and sedative properties of the roots of Nauclea latifolia Smith in mice, pp.434-440, 2009. ,
Responsible Prescribing of Opioids for the Management of Chronic Pain, Drugs, vol.330, issue.1, pp.17-32, 2003. ,
DOI : 10.2165/00003495-200363010-00002
Central pain in multiple sclerosis - prevalence and clinical characteristics, European Journal of Pain, vol.61, issue.Suppl 3, pp.531-573, 2005. ,
DOI : 10.1016/j.ejpain.2004.11.005
D-Maurocalcine, a Pharmacologically Inert Efficient Cell-penetrating Peptide Analogue, Journal of Biological Chemistry, vol.285, issue.44, pp.34168-34180, 2010. ,
DOI : 10.1074/jbc.M110.104919
URL : https://hal.archives-ouvertes.fr/inserm-00587800
Clinical pharmacokinetics: concepts and applications. Chapter 19, Lea and Febiger, vol.2, 1989. ,
The catalepsy test: Its ups and downs., Behavioral Neuroscience, vol.102, issue.5, pp.748-759, 1988. ,
DOI : 10.1037/0735-7044.102.5.748
Naucleamides A???E, New Monoterpene Indole Alkaloids from Nauclea latifolia, CHEMICAL & PHARMACEUTICAL BULLETIN, vol.51, issue.1, pp.58-61, 2002. ,
DOI : 10.1248/cpb.51.58
A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury, Pain, vol.103, issue.3, pp.249-57, 2003. ,
DOI : 10.1016/S0304-3959(02)00452-9
Pharmacologic treatment of pain in polyneuropathy, Neurology, vol.55, issue.7, pp.915-935, 2000. ,
DOI : 10.1212/WNL.55.7.915
Antidepressant, myorelaxant and anti-anxietylike effects of Nauclea latifolia Smith (Rubiaceae) roots extract in murine models, International Journal of Pharmacology, vol.6, pp.326-333, 2010. ,
root decoction and possible mechanisms of action, Pharmaceutical Biology, vol.8, issue.1, pp.15-25, 2011. ,
DOI : 10.1126/science.1273597
Molecular mechanism of neuropathic pain, Drug News & Perspectives, vol.16, issue.9, pp.605-618, 2003. ,
DOI : 10.1358/dnp.2003.16.9.829343
The prevalence of neuropathic pain after non-traumatic spinal cord lesion, Spinal Cord, vol.33, issue.9, pp.609-615, 2007. ,
DOI : 10.1038/sj.sc.3102000